Skip to main content

How RWE can help Biotechs optimize the value of their asset

Matthew Gordon, VP of Real-World Evidence Strategy, Parexel, and Jimmy Brown, VP, Parexel Biotech discuss how RWE is a tremendously versatile tool for biotech companies at all stages.

Download PDF